Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q4 2025 value amounting to 0.22.
- Enanta Pharmaceuticals' Asset Utilization Ratio rose 1954.92% to 0.22 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22, marking a year-over-year increase of 1954.92%. This contributed to the annual value of 0.2 for FY2025, which is 2325.55% up from last year.
- According to the latest figures from Q4 2025, Enanta Pharmaceuticals' Asset Utilization Ratio is 0.22, which was up 1954.92% from 0.22 recorded in Q3 2025.
- In the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.24 in Q1 2023 and a low of 0.17 during Q4 2023
- Its 5-year average for Asset Utilization Ratio is 0.2, with a median of 0.21 in 2025.
- In the last 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio tumbled by 4218.92% in 2021 and then soared by 2874.29% in 2025.
- Over the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then grew by 7.4% to 0.23 in 2022, then decreased by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then increased by 19.55% to 0.22 in 2025.
- Its Asset Utilization Ratio stands at 0.22 for Q4 2025, versus 0.22 for Q3 2025 and 0.21 for Q2 2025.